Malebari, A.M.; Wang, S.; Greene, T.F.; O’Boyle, N.M.; Fayne, D.; Khan, M.F.; Nathwani, S.M.; Twamley, B.; McCabe, T.; Zisterer, D.M.;
et al. Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals 2025, 18, 1219.
https://doi.org/10.3390/ph18081219
AMA Style
Malebari AM, Wang S, Greene TF, O’Boyle NM, Fayne D, Khan MF, Nathwani SM, Twamley B, McCabe T, Zisterer DM,
et al. Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals. 2025; 18(8):1219.
https://doi.org/10.3390/ph18081219
Chicago/Turabian Style
Malebari, Azizah M., Shu Wang, Thomas F. Greene, Niamh M. O’Boyle, Darren Fayne, Mohemmed Faraz Khan, Seema M. Nathwani, Brendan Twamley, Thomas McCabe, Daniela M. Zisterer,
and et al. 2025. "Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119" Pharmaceuticals 18, no. 8: 1219.
https://doi.org/10.3390/ph18081219
APA Style
Malebari, A. M., Wang, S., Greene, T. F., O’Boyle, N. M., Fayne, D., Khan, M. F., Nathwani, S. M., Twamley, B., McCabe, T., Zisterer, D. M., & Meegan, M. J.
(2025). Correction: Malebari et al. Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4. Pharmaceuticals 2021, 14, 1119. Pharmaceuticals, 18(8), 1219.
https://doi.org/10.3390/ph18081219
